Methenamine is frequently prescribed for patients who have chronic urinary infection to
suppress bacterial growth during active infection or to prevent recurrence once an infection …

This study was designed to determine the effect of methenamine on the frequency of urinary
tract infections (UTI) in hospitalized patients after spinal cord injury. The study included 56 …

Twenty‐four patients with a history of recurrent urinary tract infection and in whom residual
urine was considered to be a factor of importance for chronicity, have been treated for an …

The antimicrobial activity of urine collected from adult male paraplegics ingesting
methenamine mandelate (MM) was evaluated. The in vitro bacterial growth in urine from …

We studied prospectively 40 patients with recent spinal cord injuries to determine the
effectiveness of the combination of oral methenamine and an intravesicular acidifying agent …

Oral treatment with methenamine‐hippurate (MH) in patients with an indwelling catheter has
been found to reduce the need of frequent catheter exchange and the number of …

We studied the effectiveness of methenamine mandelate in preventing urinary tract infection
in patients with neurogenic bladder dysfunction who were in a program of intermittent …

Acute study. Nine patients were treated with 2 gm. per day in divided doses for 4 weeks and
2 more were treated for 17 and 21 days respectively. In these 11 patients the urine became …

Data from serial follow-up evaluations of 103 patients with traumatic or atraumatic
myelopathy were recorded to determine rates significant bacteriuria in groups using different …

The mechanism of action, spectrum of antimicrobial activity, pharmacokinetics, adverse
effects, therapeutic use, and dosage of methenamine hippurate and methenamine …